Vincerx Pharma Inc
NASDAQ:VINC

Watchlist Manager
Vincerx Pharma Inc Logo
Vincerx Pharma Inc
NASDAQ:VINC
Watchlist
Price: 0.0125 USD Market Closed
Market Cap: 65.4k USD

Operating Margin
Vincerx Pharma Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-31.5m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Vincerx Pharma Inc
Glance View

Market Cap
65.4k USD
Industry
Biotechnology

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. The company is headquartered in Palo Alto, California and currently employs 56 full-time employees. The company went IPO on 2020-03-10. The Company’s small molecule drug program includes VIP152, which is a highly selective, clinical-stage positive transcription elongation factor-beta/cyclin-dependent kinase 9 (PTEFb/CDK9) inhibitor. The firm's antibody-drug conjugate (ADC) platform includes VIP943 (targeting CD123) and VIP924 (targeting CXCR5), which are ADC compounds addressing known and novel oncology targets. The Company’s bioconjugation program also includes VIP236, which is a small molecule drug conjugate (SMDC) for solid tumors.

VINC Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-31.5m
/
Revenue
0
What is the Operating Margin of Vincerx Pharma Inc?

Based on Vincerx Pharma Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top